Clinical Trial Update: Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating reactive focal mass drug administration with or without reactive focal vector control for malaria in Namibia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 3 | Status: COMPLETED